Overview

Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome

Status:
Terminated
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The investigators will randomize patients admitted to hospital with Takotsubo diagnosis to systematic high-dose adenosine infusion for 3 minutes (in addition to standard of care) vs. standard of care. The primary aim of the study is to demonstrate that adenosine infusion is associated with a larger and more rapid recovery of left ventricle function.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital of Ferrara
Treatments:
Adenosine
Pharmaceutical Solutions